US$ 22.40
semaglutide drug type Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Health Rounds: Novo Nordisk's semaglutide
Description
These injections aren't completely without risks

Support immunity & gut health with Colostrum-IgG
DHA-licensed specialists

May also be prescribed as part of a weight management plan in individuals with overweight or obesity (as directed by a healthcare provider)

FDA-approved in the U.S., UK approved in June 2026.
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
Choose Your Program
